Monoclonal Antibody Treatment for COVID-19 helps reduce the severe risks and symptoms from appearing, but it is not intended for everyone. The FDA reserves the use of the said treatment to specific cases, and if that criteria is met by a COVID-positive patient, it would be given to them within the first 10 days of the virus. 

There are no approved treatments or medicine with regards to COVID-19 as of now, even though the widely popular Ivermectin is gathering waves of support from doctors and patients against the virus. 

Monoclonal Antibody Treatment for COVID-19

Monoclonal Antibody Treatment for COVID-19
(Photo : Go Nakamura/Getty Images)
Monoclonal Antibody Treatment for COVID-19

According to KALB 5, the Monoclonal Antibody Treatment is being adopted by health professionals in different hospitals around the US, as it is something that the FDA has advised for specific cases. However, it is not something that people can receive as per request, and there are certain criteria needed to be met for this to be used.

It was not revealed by the doctors what the criteria are, but it highly focuses on those who are subject to getting severe cases or symptoms brought by the virus. High-risk people for COVID-19 can also receive this, and the criteria for this may be as follows:

  • Fever
  • Fatigue
  • Loss of Taste and Smell
  • Low Blood Oxygen (SpO2)
  • Cough
  • Colds

Some people are already subject to these symptoms at a severe case profile in the early days of their COVID-19 infection, and they might be subject to said treatment. 

However, if symptoms worsen people, might not be able to get this treatment anymore, as it is not recommended by the FDA for cases longer than 10 days or have already shown a bad case of symptoms for the virus. 

Read Also: Facebook Blocks COVID-19 Misinformation Researchers from NYU, Cuts off Access to Ad Library

What is Monoclonal Antibody Treatment?

Monoclonal Antibody Treatment for COVID-19
(Photo : John Moore/Getty Images)
Monoclonal Antibody Treatment for COVID-19

The FDA has given the Monoclonal Antibody Treatment an Emergency Use Authorization for the Mild to Moderate cases, so that it may not transcend or worsen into a severe case. The main purpose of the said treatment is to prevent people from getting a bad case of the virus and speed up their healing process. 

Additionally, the FDA is only advising this to help people in recovering from COVID-19, and it is not a "medicine" per se or a treatment that can be used globally. The country's health agency is still determining its use for a wide application, especially for people that get infected. 

Moreover, it remains under study and EUA. 

Why Are There No Approved Treatment for COVID-19?

COVID-19's current status as a virus is still progressive, and it changes every day as health professionals monitor it. Initially, the COVID-19 was on its way to recovery, but then the Delta Variant popped up and gave people another thing to be scared of, and avoid. 

While the vaccination rate of the country is slowly rising as anti-vaxxers flood social media, the best defense against the virus would still be the immunization shots. Prevention is better than treatment, especially for COVID-19.

Related Article: Alerts on NHS COVID App Decline in England, Wales Users, According to Latest Statistics

This article is owned by Tech Times

Written by Isaiah Richard

ⓒ 2021 All rights reserved. Do not reproduce without permission.